Timothy J. Sangiovanni, SVP, Finance & Corporate Controller at ZEVRA THERAPEUTICS, INC. (ZVRA), sold 3,500 shares at $8.82 ($31K) on 2026-01-30, disclosed to the SEC on 2026-02-02.
Open-market sale of $31k ZVRA by SVP, Finance & Corporate Controller. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.82 | 1,750 | $15K | 50.0% |
| 2 | $8.82 | 1,750 | $15K | 50.0% |
| Total | $8.82 avg | 3,500 | $31K | 100% |
| Filing → |
| ZVRA | BUY | 2023-03-13 | $5K | — | Filing → |
| KMPH | BUY | 2020-03-16 | $800 | — | Filing → |
| KMPH | BUY | 2020-03-10 | $2K | — | Filing → |